Primary and secondary HIV-1 drug resistance mutations present in patients attending health centres in Maputo, Mozambique

被引：0
|
作者：
Ramalho, D. C. [1 ,2 ]
Abreu, C. [2 ]
Bullousa, L. [2 ]
Francisco, C. [1 ]
Jani, V. I. [1 ]
Bhatt, N. [1 ]
Ismael, N. [1 ]
Tanuri, A. [2 ]
Bila, D. C. [1 ]
机构：
[1] Inst Nacl Saude, Maputo, Mozambique
[2] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
来源：
ANTIVIRAL THERAPY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
103
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [21] Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
    Bennett, Diane E.
    Camacho, Ricardo J.
    Otelea, Dan
    Kuritzkes, Daniel R.
    Fleury, Herve
    Kiuchi, Mark
    Heneine, Walid
    Kantor, Rami
    Jordan, Michael R.
    Schapiro, Jonathan M.
    Vandamme, Anne-Mieke
    Sandstrom, Paul
    Boucher, Charles A. B.
    van de Vijver, David
    Rhee, Soo-Yon
    Liu, Tommy F.
    Pillay, Deenan
    Shafer, Robert W.
    PLOS ONE, 2009, 4 (03):
  • [22] HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia
    Hamers, Raph L.
    Siwale, Margaret
    Wallis, Carole L.
    Labib, Moheb
    van Hasselt, Robbert
    Stevens, Wendy S.
    Schuurman, Rob
    Wensing, Annemarie M. J.
    Van Vugt, Michele
    de Wit, Tobias F. Rinke
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (01) : 95 - 101
  • [23] Slower serological evolution in primary HIV-1 drug resistance
    Truong, HM
    Hecht, FM
    Barbour, JD
    Busch, MP
    Liegler, T
    Grant, RM
    ANTIVIRAL THERAPY, 2004, 9 (04) : U76 - U77
  • [24] HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis
    Goncalves, Paloma
    Mascarenhas, Paulo
    Marcelino, Rute
    Mabunda, Nedio
    Kroidl, Arne
    Buck, W. Chris
    Jani, Ilesh
    Palladino, Claudia
    Taveira, Nuno
    VIRUSES-BASEL, 2024, 16 (12):
  • [25] ASSESSMENT OF HIV-1 PRIMARY DRUG RESISTANCE MUTATIONS IN ANTIRETROVIRAL THERAPY-NAIVE CASES IN MOROCCO
    Eloudyi, H.
    Lemrabet, S.
    Malmoussi, M.
    Ouagari, Z.
    Elharti, E.
    Akrim, M.
    Oumzil, H.
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A233 - A234
  • [26] HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
    Shafer, Robert W.
    Rhee, Soo-Yon
    Pillay, Deenan
    Miller, Veronica
    Sandstrom, Paul
    Schapiro, Jonathan M.
    Kuritzkes, Daniel R.
    Bennett, Diane
    AIDS, 2007, 21 (02) : 215 - 223
  • [27] An HIV-1 integrase genotype assay for the detection of drug resistance mutations
    Hearps, Anna C.
    Greengrass, Vicki
    Hoy, Jennifer
    Crowe, Suzanne M.
    SEXUAL HEALTH, 2009, 6 (04) : 305 - 309
  • [28] Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal
    Bhusal, Nirajan
    Sutthent, Ruengpung
    Horthongkham, Navin
    Athipanyasilp, Niracha
    Kantakamalakul, Wannee
    CURRENT HIV RESEARCH, 2016, 14 (06) : 517 - 524
  • [29] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92
  • [30] HIV-1 C proviral DNA for detection of drug resistance mutations
    Huruy, Kahsay
    Mulu, Andargachew
    Liebert, Uwe Gerd
    Melanie, Maier
    PLOS ONE, 2018, 13 (10):
12345